Arca Biopharma sell StockNews.com
Start price
17.07.24
/
50%
€3.18
Target price
17.07.25
-
Performance (%)
57.47%
Price
30.08.24
€2.22
Summary
This prediction is currently active. The price for Arca Biopharma has massively increased, which is bad news for the SELL prediction by StockNews_com. Dividends of €2.85 are taken into consideration when calculating the performance. This prediction currently runs until 17.07.25. The prediction end date can be changed by StockNews_com at any time. StockNews_com has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Arca Biopharma | -2.632% | -2.632% |
iShares Core DAX® | -1.414% | 7.218% |
iShares Nasdaq 100 | -2.316% | 4.450% |
iShares Nikkei 225® | -2.756% | 10.071% |
iShares S&P 500 | -1.849% | 4.760% |
Comments by StockNews_com for this prediction
In the thread Arca Biopharma diskutieren
ARCA biopharma, Inc. (NASDAQ: ABIO) was upgraded by analysts at StockNews.com to a "sell" rating.
Ratings data for ABIO provided by MarketBeat